Literature DB >> 34089734

New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting.

Elisabeth Hessmann1, Günter Schneider2.   

Abstract

Pancreatic ductal adenocarcinoma remains a major challenge in cancer medicine. Given the increase in incidence and mortality, interdisciplinary research is necessary to translate basic knowledge into therapeutic strategies improving the outcome of patients. On the 4th and 5th of February 2021, three German pancreatic cancer research centers, the Clinical Research Unit 5002 from Göttingen, the Collaborative Research Center 1321 from Munich, and Clinical Research Unit 325 from Marburg organized the 1st Virtual Göttingen-Munich-Marburg Pancreatic Cancer Meeting in order to foster scientific exchange. This report summarizes current research and proceedings presented during that meeting.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Emerging Therapies; Genome Dynamics; Microenvironment; Molecular Subtypes; Pancreatic Cancer

Mesh:

Substances:

Year:  2021        PMID: 34089734     DOI: 10.1053/j.gastro.2021.04.082

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  3 in total

1.  Combined Inhibition of FOSL-1 and YAP Using siRNA-Lipoplexes Reduces the Growth of Pancreatic Tumor.

Authors:  Lara Diego-González; Andrea Fernández-Carrera; Ana Igea; Amparo Martínez-Pérez; M Elisabete C D Real Oliveira; Andreia C Gomes; Carmen Guerra; Mariano Barbacid; África González-Fernández; Rosana Simón-Vázquez
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

2.  SIRT5's GOT1 up on PDAC.

Authors:  Surinder Kumar; David B Lombard
Journal:  Gastroenterology       Date:  2021-07-16       Impact factor: 22.682

3.  Indirect targeting of MYC sensitizes pancreatic cancer cells to mechanistic target of rapamycin (mTOR) inhibition.

Authors:  Christian Schneeweis; Zonera Hassan; Katja Ascherl; Matthias Wirth; Stella Koutsouli; Felix Orben; Lukas Krauß; Carolin Schneider; Rupert Öllinger; Oliver H Krämer; Roland Rad; Maximilian Reichert; Maria S Robles; Dieter Saur; Günter Schneider
Journal:  Cancer Commun (Lond)       Date:  2022-03-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.